Functional Systems of Plasma Proteins in Metal Transport, Inflammatory Responses, and Tissue Injury

Plasma proteins do not merely maintain colloid osmotic pressure or serve as passive carriers, but instead constitute a core functional layer in the circulatory system for metal coordination, inflammatory reprogramming, and injury buffering. Transferrin, ceruloplasmin, albumin, haptoglobin, and hemopexin together establish an interconnected system for the transport and clearance of iron, copper, zinc, hemoglobin, and free heme, respectively. When inflammation or tissue injury occurs, the functional emphasis of these proteins shifts from homeostatic transport toward limiting exposure to reactive metals, attenuating oxidative amplification, and reshaping immune and tissue responses. Therefore, understanding plasma protein function should be placed within the unified framework of “metal transport–acute-phase reprogramming–tissue protection and injury amplification”.

 

Keywords: plasma proteins; metal transport; transferrin; ceruloplasmin; albumin; haptoglobin; hemopexin; inflammatory response; tissue injury; oxidative stress

 

I. Plasma Proteins Undertake the Dual Tasks of Metal Homeostasis and Injury Limitation

1.1 Metal transport is not a passive diffusion process

(1) Circulating metals must exist in controlled coordination states

Iron, copper, zinc, and heme all possess marked chemical reactivity. If they remain in free or weakly bound forms within the plasma environment, they are more likely to participate in redox reactions, lipid peroxidation, and protein damage. Therefore, the primary role of plasma proteins is not simply to move metals, but to constrain these reactive ligands within controlled coordination states.

(2) Different proteins control different categories of metal-related risk

Transferrin mainly mediates circulating delivery of ferric iron, ceruloplasmin maintains the safe oxidative state of iron after export as a copper-containing ferroxidase, albumin plays a decisive role in plasma zinc distribution, and haptoglobin and hemopexin establish high-affinity clearance barriers for free hemoglobin and free heme, respectively.

 

1.2 Inflammation actively rewrites the metal distribution pattern of plasma proteins

(1) Under inflammatory conditions, the body reduces circulating bioavailable iron

Inflammatory stimulation can induce hepatic synthesis of hepcidin, thereby suppressing intestinal absorption and macrophage iron recycling, and rapidly producing inflammation-associated hypoferremia. The consequence is not merely a tendency toward anemia, but an active reduction in circulating iron flux available to pathogens and highly proliferative cells.

(2) This reprogramming simultaneously changes the functional roles of plasma proteins

Under homeostatic conditions, transferrin is more strongly oriented toward iron delivery; under inflammatory conditions, the relevant system instead emphasizes limiting loading, reducing efflux, and lowering exposure to reactive iron. Similarly, albumin, ceruloplasmin, and heme clearance proteins shift from basic transport roles toward injury buffering and inflammatory regulatory functions.

 

II. Functional Stratification of Core Plasma Proteins Involved in Metal Transport

2.1 Transferrin constitutes the principal axis of circulating iron delivery

(1) The core significance of transferrin lies in safe delivery rather than increased iron exposure

Iron in the circulation must be transported in a strictly coordinated state; otherwise, it is more likely to catalyze free radical reactions. By binding ferric iron, transferrin restricts iron flux to a receptor-mediated uptake framework, thereby coupling metal supply to cellular demand. During inflammation, hepcidin elevation reduces the amount of iron that can enter this delivery pathway, indicating that the transferrin system is not a constant supply mechanism, but is dynamically regulated by inflammatory signaling.

(2) Its pathological significance lies in insufficient or mismatched iron delivery

When inflammation persists, hepcidin remains chronically elevated, or iron export is impaired, reduced circulating iron can affect hematopoiesis and tissue oxygen supply. Conversely, when iron homeostasis is dysregulated, increased non-transferrin-bound iron raises the risk of oxidative injury. Thus, the value of the transferrin system lies in maintaining the boundary between usable iron and reactive iron.

 

2.2 Ceruloplasmin links iron export, copper enzyme activity, and oxidative injury control

(1) Ceruloplasmin is not merely a copper carrier, but a functional ferroxidase

Ceruloplasmin has ferroxidase activity, promotes oxidative conversion after iron export, and is associated with ferroportin stability and cellular iron efflux capacity. When ceruloplasmin function is impaired, cellular iron export is hindered and tissues become more prone to iron deposition.

(2) Its protective role is closely related to limitation of free radical injury

When ceruloplasmin function declines, tissue iron accumulation and free radical injury can increase in parallel, indicating that its role is not confined to metal transport, but directly participates in limiting iron-related oxidative toxicity. In studies of tissue injury, ceruloplasmin should therefore be regarded as an oxidative safety valve accompanying iron export.

 

2.3 Albumin is an important platform for plasma zinc distribution and redox buffering

(1) The significance of albumin in zinc transport lies in regulating the form of exchangeable zinc

Albumin is not a static zinc storage pool, but rather a regulator of plasma zinc speciation and the threshold for cellular uptake. Free fatty acids, oxidative modifications, and ligand competition can alter albumin zinc-binding capacity, thereby influencing zinc exposure levels in endothelial and immune cells.

(2) Albumin simultaneously undertakes extracellular redox buffering functions

The oxidation state of albumin Cys34 is associated with multiple oxidative stress-related diseases and can influence its binding capacity for endogenous ligands and drugs. This means that albumin is not only a transport protein, but also a direct bearer of oxidative burden in the circulation and a functional readout molecule.

 

III. Hemoglobin- and Heme-Clearance Proteins Are Central to the Tissue Injury Limitation System

3.1 Haptoglobin limits the oxidative toxicity of free hemoglobin

(1) Haptoglobin establishes the first buffering barrier by binding free hemoglobin

After hemolysis, extracellular hemoglobin can exert marked oxidative stress on the vasculature and kidney. Once haptoglobin forms a complex with hemoglobin, the complex can be cleared via CD163-mediated uptake, thereby reducing hemoglobin residence time and oxidative exposure in the circulation.

(2) Haptoglobin deficiency amplifies organ injury

In hemolysis-related models, insufficient haptoglobin can lead to increased renal lipid peroxidation, enhanced DNA oxidative injury, and aggravated renal dysfunction, indicating that haptoglobin is not a peripheral protein, but an important component of anti-hemolytic tissue protection.

 

3.2 Hemopexin limits the inflammatory amplification effect of free heme

(1) Hemopexin is the principal plasma protein responsible for free heme clearance

Once heme dissociates from hemoglobin, it can function as a damage-associated molecular pattern and amplify complement, endothelial, and immune responses. Hemopexin binds free heme with extremely high affinity and completes clearance through receptor-mediated pathways, making it a key system for limiting heme toxicity.

(2) Its protective effect is reflected in limiting complement and inflammatory amplification

In hemolysis and tissue injury settings, hemopexin supplementation can reduce excessive complement activation, lower oxidative burden, and improve organ function readouts, indicating that its role is not simply passive heme carriage, but active suppression of tissue injury cascades.

 

IV. Inflammatory Responses Systemically Remodel Plasma Protein Profiles and Functional Output

4.1 The acute-phase response changes protein functional architecture, not merely concentration

(1) During inflammation, different plasma proteins show divergent directional changes

Some proteins are more strongly upregulated to reinforce limitation and clearance, such as haptoglobin and ceruloplasmin; others may become depleted or functionally impaired under severe inflammation or high injury burden, such as hemopexin, which can decline markedly when heme load increases.

(2) Protein modification state also has biological significance

Increased oxidation of albumin Cys34 is not only a marker of oxidative burden, but is also accompanied by altered ligand-binding capacity. This indicates that under inflammation and tissue injury conditions, plasma protein studies must assess not only abundance, but also whether oxidatively modified proteins still retain their original transport and buffering functions.

 

4.2 Metal restriction is itself part of the immune strategy

(1) Inflammation-associated hypoferremia is not merely a metabolic side effect

Inflammation-induced upregulation of hepcidin and suppression of serum iron indicate that the body actively reconstructs the infectious and inflammatory environment by reducing circulating bioavailable iron. This process affects both metal availability to pathogens and the metabolic and repair status of host tissues.

(2) Heme and hemoglobin clearance reflects a damage-limiting immune logic

When tissue injury or hemolysis releases heme and hemoglobin, haptoglobin and hemopexin clear these highly reactive molecules, thereby interrupting complement, oxidative, and endothelial activation cascades. Plasma proteins therefore do not merely transport metals; they also define whether inflammation resolves within a controlled range or becomes persistently amplified.

 

V. Functional Conversion of Plasma Proteins in Tissue Injury Settings

5.1 Hemolytic and ischemia-reperfusion injury most clearly illustrate their protective roles

(1) During hemolysis, plasma proteins shift from transport systems to clearance systems

Hemoglobin and heme are physiological molecules within erythrocytes, but become oxidative and inflammatory risk sources once they enter the plasma. At this stage, haptoglobin and hemopexin undertake the first and second layers of clearance, respectively, determining whether injury remains localized.

(2) The kidney and vascular endothelium are among the earliest exposed target organs

Whether in the context of aggravated renal oxidative injury caused by haptoglobin deficiency, or the suppression of renal complement activation and functional abnormalities by hemopexin supplementation in hemolytic models, these findings show that the buffering capacity of plasma proteins is directly linked to organ outcomes.

 

5.2 In the nervous system and chronic inflammatory environments, metal transport imbalance can be converted into persistent tissue injury

(1) Ceruloplasmin deficiency indicates that transport failure can evolve into tissue accumulation

Under ceruloplasmin-deficient conditions, tissue iron deposition and free radical injury can occur simultaneously, indicating that impairment of metal transport itself can become an upstream driver of chronic tissue injury.

(2) Altered albumin function indicates that destabilization of the transport platform also changes cellular exposure

When free fatty acids alter albumin zinc-binding capacity, zinc influx into endothelial cells changes accordingly; when oxidation of albumin Cys34 increases, its transport and buffering capacity also change. Such alterations have amplifying significance in metabolic inflammation, chronic vascular injury, and critical illness.

 

VI. Commonly Used Products in Related Research

6.1 Commonly Used Products for Research on Plasma Proteins in Metal Transport, Inflammatory Responses, and Tissue Injury

 

Name	CAS No.	Experimental Step	Key Use	Notes for Use
Transferrin	11096-37-0	Iron transport and receptor uptake studies	Used to construct transferrin-dependent iron delivery systems and analyze cellular responses to controlled iron input	Suitable for combined use with iron loading status, TfR1 expression, and cellular iron uptake assays
Ceruloplasmin	9031-37-2	Iron export and ferroxidase studies	Used to evaluate the roles of ceruloplasmin in iron oxidation, iron export, and buffering of oxidative injury	Suitable for combined analysis with ferroportin, iron accumulation, and lipid peroxidation indicators
Serum albumin	70024-90-7	Zinc distribution and redox buffering studies	Used to construct albumin-dependent zinc buffering systems and analyze ligand binding, fatty acid competition, and oxidative modification effects	Suitable for combined use with Zn2+, free fatty acids, and Cys34 oxidation readouts
BSA	9048-46-8	Plasma protein simulation and binding studies	Used to construct protein-binding background systems and study binding behavior of small molecules, metals, and oxidative products	Better suited for in vitro systems and methodological pilot experiments
Hemoglobin	9008-02-0	Free Hb exposure models	Used to construct hemolytic hemoglobin burden conditions and analyze oxidative stress and tissue injury	Suitable for combined use with haptoglobin, albumin, and renal injury readouts
Hemin	16009-13-5	Free heme toxicity models	Used to simulate free heme exposure and analyze complement, inflammation, and endothelial responses	Suitable for combined use with hemopexin, HO-1, and ROS indicators
Ferrous ammonium sulfate	7783-85-9	Iron-loading models	Used to construct reactive iron input backgrounds and analyze iron-related oxidative stress and protein buffering capacity	Dose should be carefully controlled, and results should be interpreted together with transferrin systems
Ferric ammonium citrate	1185-57-5	Ferric iron delivery studies	Used to simulate bioavailable iron sources and evaluate iron uptake and iron homeostasis remodeling	Suitable for combined use with transferrin systems, TfR1, and ferritin readouts
Zinc chloride	7646-85-7	Zinc distribution studies	Used to analyze albumin-dependent zinc buffering and changes in the threshold of cellular uptake	Suitable for combined use with albumin, fatty acids, and zinc transporter studies
Copper sulfate	7758-98-7	Copper-related protein function studies	Used to evaluate responses of ceruloplasmin, albumin, and oxidative stress systems to copper ions	Suitable for combined use with ferroxidase activity and oxidative injury indicators
Deferoxamine	70-51-9	Iron chelation intervention	Used to verify the role of reactive iron in oxidative injury and inflammatory amplification	Suitable for combined use with iron-loading models and lipid peroxidation indicators
Deferiprone	30652-11-0	Iron chelation intervention	Used to analyze the impact of reductions in the exchangeable iron pool on tissue injury and inflammatory phenotypes	Better suited for cellular and long-term intervention models
Deferasirox	201530-41-8	Iron restriction intervention	Used to study buffering of iron overload and restriction of metal exposure	Suitable for use with chronic iron-loading models
Linoleic acid	60-33-3	Albumin allosteric regulation studies	Used to analyze effects of free fatty acids on the albumin zinc-binding site and metal distribution	Suitable for combined use with Zn2+ and albumin-binding assays
Oleic acid	112-80-1	Albumin ligand competition studies	Used to evaluate the effects of fatty acid burden on albumin binding behavior toward metals and drugs	Suitable for simulation of metabolic inflammation and high-lipid environments
Hydrogen peroxide	7722-84-1	Oxidative injury models	Used to establish exogenous oxidative stress conditions and evaluate buffering capacity of plasma proteins	Suitable for combined use with albumin oxidation, ceruloplasmin, and heme clearance studies
tert-Butyl hydroperoxide (t-BHP)	75-91-2	Lipid peroxidation models	Used to analyze the ability of plasma proteins to limit amplification of membrane lipid oxidation	Suitable for combined use with MDA, 4-HNE, and protein oxidation readouts
Malondialdehyde (MDA standard)	542-78-9	Lipid peroxidation detection	Used to evaluate the degree of lipid oxidative injury after exposure to iron, heme, or hemoglobin	Suitable for combined analysis with haptoglobin and hemopexin protection experiments
4-Hydroxynonenal (4-HNE)	75899-68-2	Oxidative byproduct studies	Used to analyze the role of plasma proteins in buffering lipid peroxidation byproducts	Suitable for albumin- and GST-related studies
C-reactive protein (CRP)	9007-41-4	Acute-phase inflammation models	Used to analyze changes in plasma protein profiles and injury responses under acute-phase conditions	Suitable for combined studies with IL-6 and acute-phase proteins

 

6.2 Research-Related Assay Kits for Plasma Protein Metal Transport, Inflammatory Responses, and Tissue Injury

 

Catalog No.	Name	Grade and Purity	Corresponding Functional Axis/Target	Suitable Research Direction/Application
EJ1513060	Mouse Haptoglobin (Hpt/HP) ELISA Kit	BioReagent	Haptoglobin-Hb clearance axis	Suitable for studies of hemolysis models, free hemoglobin buffering capacity, and kidney/vascular injury
EJ1514886	Human Hemopexin (HPX) ELISA Kit	BioReagent	Hemopexin-heme clearance axis	Suitable for studies of free heme burden, complement amplification, and inflammatory restriction
EJ1513231	Mouse Hemopexin (HPX) ELISA Kit	BioReagent	Hemopexin-heme clearance axis	Suitable for evaluation of heme clearance capacity in mouse hemolysis and tissue injury models
EJ1515084	Human Ceruloplasmin (CP/CER) ELISA Kit	BioReagent	Ceruloplasmin-ferroxidase-iron export axis	Suitable for studies of iron oxidation, iron export, and oxidative injury buffering under inflammatory conditions
EJ1512401	Rat Ceruloplasmin (CP/CER) ELISA Kit	BioReagent	Ceruloplasmin-ferroxidase-iron export axis	Suitable for studies of rat iron homeostasis imbalance and tissue iron deposition
EJ1513330	Mouse Ceruloplasmin (CP/CER) ELISA Kit	BioReagent	Ceruloplasmin-ferroxidase-iron export axis	Suitable for studies of mouse inflammation, ischemia-reperfusion, and chronic tissue injury models
C1515988	Ceruloplasmin (Cp) Activity Assay Kit (TMB, Micro Method)	BioReagent	Ceruloplasmin activity	Suitable for ferroxidase activity detection in micro-volume samples, facilitating comparison of functional changes rather than protein abundance alone
C1515989	Ceruloplasmin (Cp) Activity Assay Kit (TMB, Colorimetric Method)	BioReagent	Ceruloplasmin activity	Suitable for combined analysis of ceruloplasmin activity and oxidative stress status in routine samples
EJ1513203	Mouse Serum Ferritin(SF) ELISA Kit	BioReagent	Iron storage / inflammatory iron redistribution axis	Suitable for studies of iron restriction, inflammatory hypoferremia, and iron accumulation
S1515913	Serum Iron Content Assay Kit (2, 2‘-Bipyridine, Micro Method)	BioReagent	Circulating bioavailable iron	Suitable for evaluation of serum iron changes and inflammatory hypoferremia in micro-volume samples
S1515914	Serum Iron Content Assay Kit (2, 2’-Bipyridine, Colorimetric Method)	BioReagent	Circulating bioavailable iron	Suitable for analysis of serum iron levels and iron redistribution in routine samples
EJ1513951	Human Soluble Transferrin Receptor (sTfR) ELISA Kit	BioReagent	Transferrin receptor-iron demand axis	Suitable for studies of iron deficiency, cellular iron demand, and inflammation-related iron utilization reprogramming
EJ1515015	Human Transferrin (TRF) ELISA Kit	BioReagent	Transferrin-circulating iron delivery axis	Suitable for analysis of iron delivery capacity, transferrin loading status, and inflammation-related changes in human samples
EJ1515016	Human Transferrin Receptor (TFR) ELISA Kit	BioReagent	Transferrin receptor-iron uptake axis	Suitable for studies of iron uptake capacity, cellular iron starvation responses, and the transferrin system
EJ1512369	Rat Transferrin (TRF) ELISA Kit	BioReagent	Transferrin-circulating iron delivery axis	Suitable for studies of rat inflammation, anemia, and iron-loading models
EJ1512370	Rat Transferrin Receptor (TFR) ELISA Kit	BioReagent	Transferrin receptor-iron uptake axis	Suitable for studies of rat cellular iron uptake and tissue iron utilization
EJ1512371	Rat Transferrin Receptor 1 (TFRC) ELISA Kit	BioReagent	TFRC / major iron uptake axis	Suitable for studies of enhanced iron demand, proliferative tissues, and iron uptake under inflammatory conditions
EJ1512372	Rat Transferrin Receptor 2 (TFR2) ELISA Kit	BioReagent	TFR2 / iron homeostasis regulatory axis	Suitable for studies of hepatic iron sensing, systemic iron homeostasis, and inflammatory iron reprogramming
EJ1513292	Mouse Transferrin (TRF) ELISA Kit	BioReagent	Transferrin-circulating iron delivery axis	Suitable for studies of mouse iron transport, inflammatory hypoferremia, and tissue injury models
EJ1513293	Mouse Transferrin Receptor (TFR) ELISA Kit	BioReagent	Transferrin receptor-iron uptake axis	Suitable for evaluation of mouse iron uptake capacity and cellular iron demand status
EJ1513295	Mouse Transferrin Receptor 2 (TFR2) ELISA Kit	BioReagent	TFR2 / iron homeostasis regulatory axis	Suitable for studies of mouse systemic iron homeostasis and hepatic iron sensing
EJ1514401	Human Albumin (Albumin) ELISA Kit	BioReagent	Albumin-ligand binding and redox buffering axis	Suitable for analysis of plasma albumin levels, inflammatory consumption, and transport platform changes under tissue injury conditions
EJ1512166	Rat Albumin (ALB) ELISA Kit	BioReagent	Albumin-ligand binding and redox buffering axis	Suitable for studies of severe inflammation, hemolysis, and tissue injury models in rats
EJ1512942	Mouse Albumin (ALB) ELISA Kit	BioReagent	Albumin-ligand binding and redox buffering axis	Suitable for evaluation of plasma protein homeostasis and injury-buffering capacity in mice
A1505873	Albumin (ALB) Content Assay Kit (BCG, Micro Method)	BioReagent	Total albumin	Suitable for measurement of albumin content in micro-volume samples and for integrated analysis with oxidative modification or changes in metal-binding capacity

 

The roles of plasma proteins in metal transport, inflammatory responses, and tissue injury are not three separate topics, but different manifestations of the same functional system at different physiological and pathological stages. Under homeostatic conditions, they are responsible for safe coordination and directional delivery; during inflammation, they participate in metal redistribution and immune restriction; during injury, they shift toward buffering and clearing hemoglobin, heme, and reactive metal exposure. Research on this system should therefore be developed around the continuous logic of “transport–reprogramming–injury limitation” in order to more accurately understand the systemic functions of plasma proteins in disease development and tissue protection.

 

For more related articles, please see below:

[1] Albumin

[2] Structural Basis, Manufacturing Technologies, and Applications of Recombinant Human Albumin and Recombinant Human Transferrin

[3] Transferrin and Apo-Transferrin: Structural Features, Iron-Homeostasis Mechanisms, and Key Technical Application Points